Three Arch Partners Company Profile

14:41 EST 14th December 2018 | BioPortfolio

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fifty important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Since inception, Three Arch has focused on identifying and creating new healthcare companies in markets with significant unmet clinical or infrastructure needs. The general partners do not wait for ideas to come to them, but actively create and source technology and management. As often, the fund assists physicians and inventors in establishing companies. Our involvement may include securing capital, assembling management, technical, and regulatory teams, and providing interim operational support.


3200 Alpine Road
Portola Valley
United States of America


Phone: (650) 529-8000
Fax: (650) 529-8039

News Articles [255 Associated News Articles listed on BioPortfolio]

Arch Biopartners to Seek Regulatory Guidance From the U.S FDA for AB569

ARch Biopartners (TSXV:ARCH) has announced it will seek regulatory guidance from the US Food and Drug Administration in a pre investigational new drug application meeting for AB569, its drug candidate...

Arch Biopartners Provides Toxicology Update for Metablok

Arch Biopartners (TSXV:ARCH;OTCQB:ACHFF) today provided an update on the general results from toxicology and pharmacology studies evaluating Metablok, the Company’s lead drug candidate for treating ...

Arch Therapeutics CEO looks ahead to positive results on AC5 gel

Arch Therapeutics (OTCMKTS:ARTH, OTCQB:ARTH) CEO Dr. Terry Norchie tells Proactive Investors the biotechnology company is developing a gel called AC5 that seals and protects leaking and bleeding tis...

Karuna completes $42 million financing round

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial

The Canadian CDMO Dalton Pharma Services will manufacture Arch Biopartners' drug candidate for use in Phase I clinical trials.

Metacrine closes $65mm Series C

Metacrine Inc. (therapies for hepatic, gastrointestinal, and metabolic diseases) raised $65mm in its Series C financing led by Venrock Healthcare Partners, which was joined by first-time backers Frank...

Gossamer Bio closes $230mm Series B round

Gossamer Bio Inc. raised $230mm through its Series B round led by Hillhouse Capital. New buyers Invus, a subsidiary of the Abu Dhabi Investment Authority, the Baupost Group, and Polaris Partners were ...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]


Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [405 Associated PubMed Articles listed on BioPortfolio]

Case Series of Aortic Arch Aneurysm in Patients with Bovine Arch Treated with Proximal Scalloped and Fenestrated Stent Graft.

The bovine arch is the most common variant of the aortic arch and occurs when the innominate artery shares a common origin with the left common carotid artery. We report an endovascular repair of aort...

Mid-term results of two-stage hybrid arch repair for extensive aortic arch aneurysms.

This report evaluated the perioperative and mid-term results of the two-stage hybrid arch procedure. This procedure involves total arch replacement with an elephant trunk as the first stage and thorac...

Combined aortic arch resection for lung cancer using total rerouting of supra-arch vessels.

Surgery for aortic arch involvement in lung cancer cases is challenging, and generally requires extracorporeal circulation with circulatory arrest or a cerebral protection technique. To reduce morbidi...

Evaluation of Skeletal and Dental Effects of Lower Lingual Arches.

A lower lingual arch is usually recommended as a holding device to maintain arch length and to prevent mesial migration of the mandibular first molars. Despite its widespread use, comparatively little...

Surgical Approach for Hypoplastic Mirror Circumflex Aortic Arch.

Surgical approach for mirror-form of circumflex aortic arch with a long-segment hypoplasia is described. Instead of "uncrossing" the arch, posterior aortic translocation aorta is required for the mirr...

Clinical Trials [439 Associated Clinical Trials listed on BioPortfolio]

Comparison of Arch Expansion Changes Between Passive Self-ligating and Conventional Brackets

The purpose of this randomized controlled clinical trial was to compare the transverse development of the arches and the incisor inclination comparing two different ligating systems (SL vs...

Aortic Arch Related Cerebral Hazard Trial (ARCH)

The ARCH is a controlled trial with a sequential design and with a prospective, randomized, open-label, blinded-endpoint (PROBE) methodology. The objective is to compare the efficacy and t...

Evaluation and Classification of Foot Medial Longitudinal Arch Height in Adults

The aim of the study is, to evaluate and classificate the medial longitudinal arch height in adult individuals. Aged between 18-40 years,350 adults who are voluntarily participate is going...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Accuracy of Arch Analysis in Mixed Dentition Using Digital Models Versus Plaster Ones.

Accuracy of arch analysis in mixed dentition using digital study models versus the plaster models using Moyers prediction equation:

Companies [946 Associated Companies listed on BioPortfolio]

Three Arch Partners

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fi...


Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. End...

Arch Grants

Arch Grants creates an entrepreneurial culture and infrastructure to build successful companies in St. Louis. The organization provides $50,000 equity-free grants and pro bono sup...

Kerberos Proximal Solutions, Inc.

Kerberos Proximal Solutions was a privately-held medical device company based in Cupertino, Calif. Founded in 2001, Kerberos was dedicated to developing innovative solutions to tr...

ARCH Clinical Research

ARCH Clinical Research provides pharmaceutical and biotechnology companies with high-quality clinical research services in Australia and New Zealand. In a time- and cost-efficient manner and according...

More Information about "Three Arch Partners" on BioPortfolio

We have published hundreds of Three Arch Partners news stories on BioPortfolio along with dozens of Three Arch Partners Clinical Trials and PubMed Articles about Three Arch Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Three Arch Partners Companies in our database. You can also find out about relevant Three Arch Partners Drugs and Medications on this site too.

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record